期刊文献+

阿维菌素选择加氢制备伊维菌素的研究进展 被引量:1

The Research Development of Rh,Ru and Ir Catalysts for Selective Hydrogenation of Avermectin to Ivermectin
在线阅读 下载PDF
导出
摘要 伊维菌素是一种安全、广谱的抗寄生虫药物,目前已广泛用于人体及动物的抗寄生虫治疗。伊维菌素主要采用对阿维菌素选择性催化加氢来制备的。介绍了以铑、钌、铱及其配合物为催化剂,在均相或多相体系中对阿维菌素的催化反应,并对其加氢反应的条件、产率进行了比较。 Ivermectin is widely used in current anthelimintic therapy in livestock and human being due to its safety profile and broad-spectrum activity against endoparasites.Ivermectin is obtained by the selective hydrogenation of avermectins.In this article,we introduced the hydrogenation of avermectins based on rhodium,ruthenium,iridium and their complexes as catalyst in homogeneous and heterogeneous system,and compared their reaction conditions and yields.
出处 《贵金属》 CAS CSCD 北大核心 2010年第3期60-63,共4页 Precious Metals
关键词 催化化学 伊维菌素 阿维菌素 选择加氢 catalytic chemistry ivermectin avermectin selective hydrogenation
  • 相关文献

参考文献7

二级参考文献53

  • 1王道全.Avermectins的结构改造(综述)[J].北京农业大学学报,1994,20(4):431-437. 被引量:11
  • 2刘政军,王军,刘志俊.阿维菌素生产现状及未来发展评析[J].山东化工,2005,34(4):45-46. 被引量:7
  • 3杨志宏,王长龙,吴长英,聂基兰.微乳液的稳定性及其在制备超细Y_2O_3中的应用[J].稀有金属,2006,30(4):440-443. 被引量:6
  • 4Mrozik H,Eskola P,Linn B O. Discovery of Novel Avermectins with Unprecedented Insecticidal Activity [J]. Experientia,1989, 45(3) :315-316.
  • 5Bloom R A , Matheson I. Environmental assessment of avermectin by the US food and drug administration [ J ]. Vet Parasitd, 1993 ,48 ( 1 ) :281-294.
  • 6Chabala J C, Fisher M H. Selective hydrogenation products of C-076 compounds and derivatives thereof [P]. US: 4199569,1980-04 -22.
  • 7Roberts F, Grendavictor J. Removal of metal catalysts from process streams[ P]. EP:0,059,616,1983-08-09.
  • 8Cornils B. Aqueous-phase organometallie catalysis,2nd ed. [ M ]. London :Wiley,2004. 12-24.
  • 9Francisco S, Pilar T, Dantele T. Process for the preparation of ivermectin[ P]. WO: 1998038201,1998-03-09.
  • 10Hua C, Yao Z L, Rui X L, et al. Highly regioselective hydroformylation of 1-dodecene catalyzed by Rh-BISBIS in aqueous two-phase system [ J]. J. Mol. Catal. ,2003,198 (1):1-7.

共引文献18

同被引文献58

  • 1刘翠翠,刘重喜,王相晶,向文胜.微生物农药米尔贝霉素特性[J].世界农药,2012,34(1):35-38. 被引量:5
  • 2夏广欣,刘重喜,王相晶,向文胜.微生物源农药米尔贝霉素的应用[J].世界农药,2012,34(3):35-39. 被引量:5
  • 3刘琳琳,刘翠翠,王相晶,夏广欣,向文胜.阿维菌素类和米尔贝霉素类杀虫剂的特性[J].世界农药,2012,34(5):34-39. 被引量:5
  • 4Angela D C, Gabriele B, Emanuela D G, et al. 2014. Field clinical study evaluating the efficacy and safety of an oral formulation containing milbemycin oxime/praziqu- antel (Milbemax, Novartis Animal Health) in the che- moprevention of the zoonotic canine infection by Dirofi- laria repens[J]. Parasites and Vectors, 7: 347-354.
  • 5Baltz R H, Crawford K P, roughton M C, et al. 2001. Biosyn- thetic genes for spinosyn insecticide production. US Pat- ent 6274350[P].
  • 6Chen L, Chen J, Jiang Y Q, et al. 2009. Transcriptomics analy- ses reveal global roles of the regulator Avel in Strepto- myces avermitilis[J]. FEMS Microbiology Letters, 298 (2): 199-207.
  • 7Chio E H. 2011a. Spinosyn insecticides: Part Ⅰ. Blockbuster products from a remarkable discovery[J]. Formosan En- tomol, 31(1): 1-13.
  • 8Chio E H. 2011b. Spinosyn insecticides: Part Ⅱ. Triple win- ner of the US-EPA presidential green chemistry chal- lenge award[J]. Formosan Entomol, 31 (1): 15-23.
  • 9Claudia B, Manuela S, Stig M T, et al. 2014. Assessment of the combination of spinosad and milbemycin oxime in preventing the development of canine Angiostrongylus vasorum infections[J]. Veterinary Parasitology, 199(4) 272-277.
  • 10Crouse G D, Sparks T C, Schoonover J, et al. 2001. Recent ad- vances in the chemistry of spinosyns[J]. Pest Manage- ment Science, 57(2): 177-185.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部